| Ytd | 17.67% | |
| 1y | 29.52% |
| Open | 5.94 | Prev Close | 5.97 | Low | 5.63 | High | 5.96 | Mkt Cap | 500.72M |
| Vol | 966.09K | Avg Vol | 1.14M | EPS | -0.28 | P/E | N/A | Forward P/E | N/A |
| Beta | 2.25 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 5.51 | 200-d Avg | 5.08 | 1yr Est | 0.00 |
SRTA News
Strata Critical Medical, Inc. (SRTA) might move higher on growing optimism about its earnings prospe
The mean of analysts' price targets for Strata Critical Medical, Inc. (SRTA) points to a 47.3% upsid
Strata Critical Medical, Inc. (SRTA) shares have started gaining and might continue moving higher in
The consensus price target hints at a 60% upside potential for Strata Critical Medical, Inc. (SRTA).
Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
On Tuesday, Strata Critical Medical (NASDAQ:SRTA) discussed second-quarter financial results during
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $260.000 million-$275.000 mil
Revenue increased 60.7% year-over-year to $72.5 million in Q2 2026 Clinical revenue increased 22.6%
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies,
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
Network of experienced transplant surgeons in key markets will immediately become available to all S
Strata Critical Medical, Inc. (SRTA) was a big mover last session on higher-than-average trading vol
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company"))), today anno
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Directors bring a strong combination of technology, healthcare, national security, leadership experi
NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or
Strata Critical Medical, Inc. (SRTA) Q1 2026 Earnings Call Transcript
Strata Critical Medical (NASDAQ:SRTA) affirms FY2026 sales outlook from $260.000 million-$275.000 mi
Strata Critical Medical (NASDAQ:SRTA) reported quarterly earnings of $0.03 per share which beat the
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or
Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" or the "Company"), today annou
NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, "Strata" o
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the
Ark Invest made no trades in its six main ETFs for two straight days, a rare feat. Here's how th
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” o
Craig-Hallum analyst Bill Bonello initiates coverage on Strata Critical Medical (NASDAQ:SRTA) wit
B. Riley Securities analyst Yuan Zhi initiates coverage on Strata Critical Medical (NASDAQ:SRTA)
Strata Critical Medical is rated 'Buy' with a 12–24 month horizon, targeting 30–35% upside as valuat
Dow falls over 1,100 points as shares of Ingram Micro jump 11.8% on better-than-expected earnings. O
Strata Critical Medical, Inc. (SRTA) Q4 2025 Earnings Call Transcript
Strata Critical Medical (NASDAQ:SRTA) raises FY2026 sales outlook from $255.000 million-$270.000 mil
Strata Critical Medical (NASDAQ:SRTA) reported quarterly sales of $66.787 million which beat the ana
Strata Critical Medical, Inc. (NASDAQ:SRTA, "Strata" or the "Company")), a leading p
Lake Street analyst Benjamin Haynor assumes Strata Critical Medical (NASDAQ:SRTA) with a Buy rati
Strata Critical Medical (NASDAQ:SRTA) sees FY2025 sales of $185.000 million-$195.000 million vs $183
Strata Critical Medical (NASDAQ:SRTA) reported quarterly losses of $(0.12) per share which missed th
